Digital outcomes

Anat Mirelman; Tanya Simuni

doi:10.1016/B978-0-323-99494-1.00018-6

Digital outcomes

Anat Mirelman, Tanya Simuni

Neurology

Northwestern University

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Recent years have witnessed an increasing interest in digital health technology (DHT) within neurology (sensors, devices, specific smartphone apps) and specifically in Parkinson's disease (PD). Quantitative measures derived from digital technology have the potential to close the gap between the different assessment properties providing measures that can quantitatively and continuously monitor PD symptoms outside the clinics, that are important to patients and reflect a pathological process or response to treatment (biomarker). This chapter reviews the current state of the field and necessary next steps to position DHT as clinically and regulatory accepted outcomes in PD.

Original language	English
Title of host publication	Handbook of Digital Technologies in Movement Disorders
Publisher	Elsevier
Pages	91-107
Number of pages	17
ISBN (Electronic)	9780323994941
ISBN (Print)	9780323994958
DOIs	https://doi.org/10.1016/B978-0-323-99494-1.00018-6
State	Published - 1 Jan 2024

Keywords

Biomarkers
Clinical outcomes assessment
Digital technology
Endpoints
Patients reported outcomes

Access to Document

10.1016/B978-0-323-99494-1.00018-6

Cite this

@inbook{c510abe4a60c4346a472a71cdfe11b89,

title = "Digital outcomes",

abstract = "Recent years have witnessed an increasing interest in digital health technology (DHT) within neurology (sensors, devices, specific smartphone apps) and specifically in Parkinson's disease (PD). Quantitative measures derived from digital technology have the potential to close the gap between the different assessment properties providing measures that can quantitatively and continuously monitor PD symptoms outside the clinics, that are important to patients and reflect a pathological process or response to treatment (biomarker). This chapter reviews the current state of the field and necessary next steps to position DHT as clinically and regulatory accepted outcomes in PD.",

keywords = "Biomarkers, Clinical outcomes assessment, Digital technology, Endpoints, Patients reported outcomes",

author = "Anat Mirelman and Tanya Simuni",

year = "2024",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-99494-1.00018-6",

language = "אנגלית",

isbn = "9780323994958",

pages = "91--107",

booktitle = "Handbook of Digital Technologies in Movement Disorders",

publisher = "Elsevier",

address = "הולנד",

}

TY - CHAP

T1 - Digital outcomes

AU - Mirelman, Anat

AU - Simuni, Tanya

PY - 2024/1/1

Y1 - 2024/1/1

N2 - Recent years have witnessed an increasing interest in digital health technology (DHT) within neurology (sensors, devices, specific smartphone apps) and specifically in Parkinson's disease (PD). Quantitative measures derived from digital technology have the potential to close the gap between the different assessment properties providing measures that can quantitatively and continuously monitor PD symptoms outside the clinics, that are important to patients and reflect a pathological process or response to treatment (biomarker). This chapter reviews the current state of the field and necessary next steps to position DHT as clinically and regulatory accepted outcomes in PD.

AB - Recent years have witnessed an increasing interest in digital health technology (DHT) within neurology (sensors, devices, specific smartphone apps) and specifically in Parkinson's disease (PD). Quantitative measures derived from digital technology have the potential to close the gap between the different assessment properties providing measures that can quantitatively and continuously monitor PD symptoms outside the clinics, that are important to patients and reflect a pathological process or response to treatment (biomarker). This chapter reviews the current state of the field and necessary next steps to position DHT as clinically and regulatory accepted outcomes in PD.

KW - Biomarkers

KW - Clinical outcomes assessment

KW - Digital technology

KW - Endpoints

KW - Patients reported outcomes

UR - http://www.scopus.com/inward/record.url?scp=85189585493&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-99494-1.00018-6

DO - 10.1016/B978-0-323-99494-1.00018-6

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???

AN - SCOPUS:85189585493

SN - 9780323994958

SP - 91

EP - 107

BT - Handbook of Digital Technologies in Movement Disorders

PB - Elsevier

ER -

Digital outcomes

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this